Back to News
Market Impact: 0.3

Billionaire Daniel Loeb Was Buying 3 of My Favorite AI Stocks in Q1. Here's Why It's Not Too Late to Buy Them.

Artificial IntelligenceTechnology & InnovationCompany FundamentalsCorporate EarningsAnalyst InsightsInvestor Sentiment & Positioning

The article highlights Alphabet, Meta Platforms, and Broadcom as attractive AI-driven stocks, citing Alphabet's TPU and Gemini advantages, Meta's 33% revenue growth and 12% ad price increases, and Broadcom's AI semiconductor revenue outlook of $56 billion this fiscal year rising to well over $100 billion next year. It also notes Daniel Loeb opened or added positions in all three names in Q1, reinforcing the bullish investment case. Broadcom's post-earnings dip is framed as a buying opportunity rather than a fundamental concern.

Analysis

The common thread is not “AI exposure” but vertical integration that converts model demand into margin capture. GOOGL and META are the cleanest beneficiaries because they monetize AI through both distribution and product improvement, which means the payoff shows up first in retention, ad pricing, and cloud economics before it becomes visible in pure AI revenue lines. AVGO sits one layer lower in the stack, and the key second-order effect is that every hyperscaler that pursues custom silicon makes its networking and interconnect content richer, so Broadcom can compound even if some compute spend migrates away from Nvidia-style GPUs.

The market is still underpricing the durability of these cash flows because it is treating AI capex as a cost center instead of a competitive moat. For GOOGL, the strategic risk is not valuation but cannibalization: if AI answers compress search query monetization faster than ad formats improve, near-term earnings could wobble for 1-2 quarters even as the long-term franchise strengthens. For META, the main variable is whether incremental ad efficiency remains high enough to offset rising infrastructure intensity; if that efficiency curve bends, the multiple should compress quickly.

The most interesting contrarian read is that AVGO may have less downside than implied by the post-earnings selloff because its growth is increasingly pre-committed by customer roadmaps, not spot demand. However, that same visibility creates a hidden concentration risk: if one or two large custom-chip programs slip, sentiment can re-rate the stock sharply despite no change in the secular thesis. Broadly, the setup favors owning the platforms with distribution and monetization control, while using AVGO as the higher-beta express on AI infrastructure spending with more timing sensitivity over the next 6-12 months.